Literature DB >> 19892579

Sexual and relationship dysfunction in people with Parkinson's disease.

Annette Hand1, William K Gray, Barbara J Chandler, Richard W Walker.   

Abstract

OBJECTIVES: To quantify the extent of self-reported sexual and relationship problems in people with Parkinson's disease (PD).
METHODS: A cross-sectional correlation design was used. All people with idiopathic PD, according to the UK Brain Bank criteria, who were known to the Northumbria Healthcare NHS Trust PD service, were asked to participate. Those who consented were assessed by a research nurse during a six month period using a series of rating scales, including the Unified Parkinson's Disease Rating Scale (UPDRS), the PD Questionnaire-39, the Mini Mental State Examination (MMSE), the Szasz sexual functioning scale and, for those in long-term relationships, the Golombok Rust Inventory of Marital State.
RESULTS: Concern over sexual function was reported in 22 (25%) of the 88 participants in the study. Males (p = 0.001) and younger people with PD (p = 0.001) were significantly more likely to report problems with sexual function. Gender (p = 0.007) and UPDRS score (p = 0.045) were significant independent predictors of relationship problems. Males with PD and those with increasing functional problems (UPDRS score) were more likely to report problems in their relationship. Disease duration and levels of anxiety and depression (Hospital Anxiety and Depression scale) were not associated with sexual or relationship problems.
CONCLUSIONS: Sexual and relationship dysfunction was a problem for many people in this study, but these problems were unlikely to be volunteered unless specifically enquired about. Problems were apparent across all age groups and genders. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19892579     DOI: 10.1016/j.parkreldis.2009.10.007

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  8 in total

1.  Management of sexual dysfunction in Parkinson's disease.

Authors:  Gila Bronner; David B Vodušek
Journal:  Ther Adv Neurol Disord       Date:  2011-11       Impact factor: 6.570

2.  The impact of Parkinson disease on patients' sexuality and relationship.

Authors:  C Buhmann; S Dogac; E Vettorazzi; U Hidding; C Gerloff; T P Jürgens
Journal:  J Neural Transm (Vienna)       Date:  2016-11-16       Impact factor: 3.575

Review 3.  Dopaminergic Therapies for Non-motor Symptoms in Parkinson's Disease.

Authors:  Eva Schaeffer; Daniela Berg
Journal:  CNS Drugs       Date:  2017-07       Impact factor: 5.749

4.  Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis?

Authors:  M A Qamar; A Sauerbier; M Politis; H Carr; P Loehrer; K Ray Chaudhuri
Journal:  NPJ Parkinsons Dis       Date:  2017-01-25

5.  Discussing sexuality with patients with Parkinson's disease: a survey among Dutch neurologists.

Authors:  Petra J M van Hees; Anton A van der Plas; Gaby F van Ek; Hein Putter; Brenda L Den Oudsten; Marjolein E M den Ouden; Henk W Elzevier
Journal:  J Neural Transm (Vienna)       Date:  2016-11-24       Impact factor: 3.575

6.  Gender gap in deep brain stimulation for Parkinson's disease.

Authors:  Stefanie T Jost; Lena Strobel; Alexandra Rizos; Philipp A Loehrer; Keyoumars Ashkan; Julian Evans; Franz Rosenkranz; Michael T Barbe; Gereon R Fink; Jeremy Franklin; Anna Sauerbier; Christopher Nimsky; Afsar Sattari; K Ray Chaudhuri; Angelo Antonini; Lars Timmermann; Pablo Martinez-Martin; Monty Silverdale; Elke Kalbe; Veerle Visser-Vandewalle; Haidar S Dafsari
Journal:  NPJ Parkinsons Dis       Date:  2022-04-20

Review 7.  The Role of Sex Therapy in the Management of Patients with Parkinson's Disease.

Authors:  Gila Bronner; Amos D Korczyn
Journal:  Mov Disord Clin Pract       Date:  2017-11-16

8.  Effect of kaempferol on the transgenic Drosophila model of Parkinson's disease.

Authors:  Falaq Naz; Smita Jyoti; Yasir Hasan Siddique
Journal:  Sci Rep       Date:  2020-08-14       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.